U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
DANAPAROID
BI6GY4U9CW
US Previously Marketed
First approved in 1996
General
Record Details
Names
3
Classification
2
Identifiers
10
Mixture Components
3
DANAPAROID
BI6GY4U9CW
US Previously Marketed
First approved in 1996
General
Approval Year
1996
225
Record Details
Substance Class
Mixture
Record UNII
BI6GY4U9CW
Record Status
Validated (UNII)
Record Version
11
10
9
8
7
6
5
4
3
2
1
Names
3
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
DANAPAROID
Common Name
English
DANAPAROID [VANDF]
Common Name
English
Danaparoid [WHO-DD]
Common Name
English
Showing 1 to 3 of 3 entries
Previous
1
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Heparin group
ATC
BLOOD AND BLOOD FORMING ORGANS
ANTITHROMBOTIC AGENTS
ANTITHROMBOTIC AGENTS
Heparin group
danaparoid
WHO-ATC
B01AB09
Heparin group
VATC
ANTITHROMBOTIC AGENTS
ANTITHROMBOTIC AGENTS
Heparin group
danaparoid
WHO-VATC
QB01AB09
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
308068-55-5
PRIMARY
IUPHAR
6804
PRIMARY
EVMPD
SUB13531MIG
PRIMARY
DRUG BANK
DB06754
PRIMARY
RXCUI
78484
PRIMARY
RxNorm
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Mixture Components
3
All of the following components
must
be present:
47959853R5
HEPARAN SULFATE (PORCINE 5500 MW)
J3OC7JVS54
DERMATAN SULFATE (PORCINE; 5500 MW)
56C14G5FWO
CHONDROITIN SULFATE (PORCINE; 5500 MW)
Definition References
(2)
